Literature DB >> 28097374

Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate.

Paul J Fletcher1,2,3, Fiona D Zeeb4,5, Caleb J Browne4,6, Guy A Higgins7,8, Ashlie D Soko4.   

Abstract

OBJECTIVES: These experiments examined the effects of selective 5-HT1A, 5-HT2A and 5-HT2C receptor ligands on responding for a conditioned reinforcer (CRf). Effects of these ligands were measured under basal conditions and following elevated dopamine (DA) activity produced by the DA reuptake inhibitor methylphenidate.
METHODS: Water-restricted rats learned to associate a conditioned stimulus (CS) with water in operant chambers. Subsequently, two response levers were made available; responding on one lever delivered the CS (now a CRf), while responding on the second lever had no consequences. The effects of agonist and antagonists of 5-HT1A (8-hydroxy-2(di-n-propylamino)tetralin hydrobromide (8-OH-DPAT) and N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinylcyclohexanecarboxamide (WAY100635)), 5-HT2A (DOI and M100907) and 5-HT2C (Ro60-0175 and SB242084) receptors on responding were examined alone, as well as in the presence of methylphenidate.
RESULTS: Responding for a CRf was reduced by the agonists 8-OH-DPAT, DOI and Ro60-0175. 8-OH-DPAT also reduced responding for water and seemed to impair responding in a non-specific fashion. None of the receptor antagonists affected responding. Methylphenidate dose-dependently enhanced responding for a CRf, and this was attenuated by DOI and Ro60-0175. Conversely, the 5-HT2C receptor antagonist SB242084 potentiated the effect of methylphenidate.
CONCLUSIONS: No evidence was found for a behaviourally selective effect of 5-HT1A receptor ligands on responding for a CRf. Activation of 5-HT2A receptors selectively inhibits responding for a CRf. 5-HT2C receptor ligands exerted bidirectional modulation of responding for a CRf, especially when DA activity was increased. This indicates that 5-HT2C receptor activity is an important modulator of DA-dependent reward-related behaviours.

Entities:  

Keywords:  5-HT1A receptors; 5-HT2A receptors; 5-HT2C receptors; Conditioned reinforcer; Methylphenidate; Serotonin

Mesh:

Substances:

Year:  2017        PMID: 28097374     DOI: 10.1007/s00213-017-4529-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  93 in total

1.  Meta-analysis of cue-reactivity in addiction research.

Authors:  B L Carter; S T Tiffany
Journal:  Addiction       Date:  1999-03       Impact factor: 6.526

2.  Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex.

Authors:  Elizabeth A Pehek; Christine Nocjar; Bryan L Roth; Tara A Byrd; Omar S Mabrouk
Journal:  Neuropsychopharmacology       Date:  2006-02       Impact factor: 7.853

3.  5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential.

Authors:  J R Martin; M Bös; F Jenck; J Moreau; V Mutel; A J Sleight; J Wichmann; J S Andrews; H H Berendsen; C L Broekkamp; G S Ruigt; C Köhler; A M Delft
Journal:  J Pharmacol Exp Ther       Date:  1998-08       Impact factor: 4.030

4.  The acquisition of responding with conditioned reinforcement: effects of pipradrol, methylphenidate, d-amphetamine, and nomifensine.

Authors:  T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1978-06-15       Impact factor: 4.530

5.  Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of D-amphetamine.

Authors:  L H Burns; T W Robbins; B J Everitt
Journal:  Behav Brain Res       Date:  1993-06-30       Impact factor: 3.332

6.  SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system.

Authors:  V Di Matteo; G Di Giovanni; M Di Mascio; E Esposito
Journal:  Neuropharmacology       Date:  1999-08       Impact factor: 5.250

7.  Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists.

Authors:  J S Sprouse; G K Aghajanian
Journal:  Synapse       Date:  1987       Impact factor: 2.562

8.  Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: potential sites for modulation of mesolimbic dopamine neurons.

Authors:  E J Van Bockstaele; D M Cestari; V M Pickel
Journal:  Brain Res       Date:  1994-06-06       Impact factor: 3.252

9.  Lesions of the orbitofrontal but not medial prefrontal cortex disrupt conditioned reinforcement in primates.

Authors:  Andrew Pears; John A Parkinson; Lucy Hopewell; Barry J Everitt; Angela C Roberts
Journal:  J Neurosci       Date:  2003-12-03       Impact factor: 6.167

10.  Symmetrical effects of amphetamine and alpha-flupenthixol on conditioned punishment and conditioned reinforcement: contrasts with midazolam.

Authors:  A S Killcross; B J Everitt; T W Robins
Journal:  Psychopharmacology (Berl)       Date:  1997-01       Impact factor: 4.530

View more
  3 in total

1.  Pharmacological evidence that 5-HT2C receptor blockade selectively improves decision making when rewards are paired with audiovisual cues in a rat gambling task.

Authors:  Wendy K Adams; Chris Barkus; Jacqueline-Marie N Ferland; Trevor Sharp; Catharine A Winstanley
Journal:  Psychopharmacology (Berl)       Date:  2017-07-21       Impact factor: 4.530

2.  Effects of 5-HT2A receptor stimulation on economic demand for fentanyl after intermittent and continuous access self-administration in male rats.

Authors:  David Alexander Martin; Utsav Gyawali; Donna J Calu
Journal:  Addict Biol       Date:  2020-05-26       Impact factor: 4.280

Review 3.  A Role for Serotonin in Modulating Opposing Drive and Brake Circuits of Impulsivity.

Authors:  Stephanie S Desrochers; Mitchell G Spring; Katherine M Nautiyal
Journal:  Front Behav Neurosci       Date:  2022-02-17       Impact factor: 3.558

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.